nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—IKBKB—Mesalazine—Crohn's disease	0.117	0.418	CbGbCtD
Acetylsalicylic acid—Salicylate-sodium—Mesalazine—Crohn's disease	0.117	0.458	CrCrCtD
Acetylsalicylic acid—migraine—Prednisone—Crohn's disease	0.116	0.508	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—Crohn's disease	0.112	0.492	CpDpCtD
Acetylsalicylic acid—Salicylamide—Mesalazine—Crohn's disease	0.0714	0.279	CrCrCtD
Acetylsalicylic acid—Salicylic acid—Mesalazine—Crohn's disease	0.0673	0.263	CrCrCtD
Acetylsalicylic acid—IKBKB—Sulfasalazine—Crohn's disease	0.0655	0.234	CbGbCtD
Acetylsalicylic acid—PTGS2—Crohn's disease	0.0647	0.529	CbGaD
Acetylsalicylic acid—ALB—Crohn's disease	0.0577	0.471	CbGaD
Acetylsalicylic acid—PTGS2—Balsalazide—Crohn's disease	0.021	0.0751	CbGbCtD
Acetylsalicylic acid—PTGS1—Balsalazide—Crohn's disease	0.0178	0.0634	CbGbCtD
Acetylsalicylic acid—PTGS2—Mesalazine—Crohn's disease	0.0168	0.06	CbGbCtD
Acetylsalicylic acid—PTGS1—Mesalazine—Crohn's disease	0.0142	0.0507	CbGbCtD
Acetylsalicylic acid—PTGS2—Sulfasalazine—Crohn's disease	0.00939	0.0335	CbGbCtD
Acetylsalicylic acid—PTGS1—Sulfasalazine—Crohn's disease	0.00793	0.0283	CbGbCtD
Acetylsalicylic acid—Reye's syndrome—Mesalazine—Crohn's disease	0.00488	0.204	CcSEcCtD
Acetylsalicylic acid—ALB—Prednisone—Crohn's disease	0.00473	0.0169	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—Crohn's disease	0.00307	0.011	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—Crohn's disease	0.00248	0.00884	CbGbCtD
Acetylsalicylic acid—Varicella—Azathioprine—Crohn's disease	0.00239	0.0995	CcSEcCtD
Acetylsalicylic acid—TP53—gall bladder—Crohn's disease	0.00149	0.0536	CbGeAlD
Acetylsalicylic acid—NFKBIA—gall bladder—Crohn's disease	0.00147	0.0527	CbGeAlD
Acetylsalicylic acid—TP53—mouth—Crohn's disease	0.00133	0.0477	CbGeAlD
Acetylsalicylic acid—NFKBIA—mouth—Crohn's disease	0.0013	0.0469	CbGeAlD
Acetylsalicylic acid—HSPA5—mouth—Crohn's disease	0.00128	0.0459	CbGeAlD
Acetylsalicylic acid—Breast feeding—Mesalazine—Crohn's disease	0.000842	0.0351	CcSEcCtD
Acetylsalicylic acid—TP53—epithelium—Crohn's disease	0.000771	0.0277	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—Crohn's disease	0.000759	0.0273	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—Crohn's disease	0.000743	0.0267	CbGeAlD
Acetylsalicylic acid—TP53—smooth muscle tissue—Crohn's disease	0.000743	0.0267	CbGeAlD
Acetylsalicylic acid—TP53—skin of body—Crohn's disease	0.000733	0.0264	CbGeAlD
Acetylsalicylic acid—NFKBIA—smooth muscle tissue—Crohn's disease	0.000731	0.0263	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—Crohn's disease	0.000722	0.0259	CbGeAlD
Acetylsalicylic acid—HSPA5—smooth muscle tissue—Crohn's disease	0.000716	0.0257	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—Crohn's disease	0.000707	0.0254	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.000702	0.0293	CcSEcCtD
Acetylsalicylic acid—TP53—mammalian vulva—Crohn's disease	0.000669	0.0241	CbGeAlD
Acetylsalicylic acid—NFKBIA—mammalian vulva—Crohn's disease	0.000658	0.0237	CbGeAlD
Acetylsalicylic acid—HSPA5—mammalian vulva—Crohn's disease	0.000645	0.0232	CbGeAlD
Acetylsalicylic acid—TP53—lymphoid tissue—Crohn's disease	0.000594	0.0214	CbGeAlD
Acetylsalicylic acid—TP53—digestive system—Crohn's disease	0.000587	0.0211	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymphoid tissue—Crohn's disease	0.000584	0.021	CbGeAlD
Acetylsalicylic acid—NFKBIA—digestive system—Crohn's disease	0.000577	0.0208	CbGeAlD
Acetylsalicylic acid—Ulcer—Mercaptopurine—Crohn's disease	0.000573	0.0239	CcSEcCtD
Acetylsalicylic acid—HSPA5—lymphoid tissue—Crohn's disease	0.000572	0.0206	CbGeAlD
Acetylsalicylic acid—HSPA5—digestive system—Crohn's disease	0.000565	0.0203	CbGeAlD
Acetylsalicylic acid—RPS6KA3—mammalian vulva—Crohn's disease	0.000549	0.0197	CbGeAlD
Acetylsalicylic acid—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.000542	0.0226	CcSEcCtD
Acetylsalicylic acid—ALB—gall bladder—Crohn's disease	0.000527	0.019	CbGeAlD
Acetylsalicylic acid—Foetor hepaticus—Mesalazine—Crohn's disease	0.000519	0.0216	CcSEcCtD
Acetylsalicylic acid—TP53—Danazol—Prednisone—Crohn's disease	0.000491	1	CbGdCrCtD
Acetylsalicylic acid—RPS6KA3—lymphoid tissue—Crohn's disease	0.000487	0.0175	CbGeAlD
Acetylsalicylic acid—IKBKB—smooth muscle tissue—Crohn's disease	0.00045	0.0162	CbGeAlD
Acetylsalicylic acid—EDNRA—mammalian vulva—Crohn's disease	0.000446	0.016	CbGeAlD
Acetylsalicylic acid—IKBKB—skin of body—Crohn's disease	0.000444	0.016	CbGeAlD
Acetylsalicylic acid—Liver disorder—Mesalazine—Crohn's disease	0.000432	0.018	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Azathioprine—Crohn's disease	0.000418	0.0174	CcSEcCtD
Acetylsalicylic acid—IKBKB—mammalian vulva—Crohn's disease	0.000405	0.0146	CbGeAlD
Acetylsalicylic acid—Gastric irritation—Prednisone—Crohn's disease	0.000402	0.0167	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Mesalazine—Crohn's disease	0.000381	0.0159	CcSEcCtD
Acetylsalicylic acid—IKBKB—lymphoid tissue—Crohn's disease	0.00036	0.0129	CbGeAlD
Acetylsalicylic acid—IKBKB—digestive system—Crohn's disease	0.000355	0.0128	CbGeAlD
Acetylsalicylic acid—SLC22A7—digestive system—Crohn's disease	0.000345	0.0124	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—Crohn's disease	0.000335	0.0121	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—Crohn's disease	0.00033	0.0119	CbGeAlD
Acetylsalicylic acid—Hepatocellular injury—Azathioprine—Crohn's disease	0.000323	0.0135	CcSEcCtD
Acetylsalicylic acid—HSPA5—lymph node—Crohn's disease	0.000323	0.0116	CbGeAlD
Acetylsalicylic acid—Gout—Mesalazine—Crohn's disease	0.000315	0.0131	CcSEcCtD
Acetylsalicylic acid—Epigastric discomfort—Prednisone—Crohn's disease	0.000296	0.0123	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Mesalazine—Crohn's disease	0.000294	0.0123	CcSEcCtD
Acetylsalicylic acid—Melaena—Mesalazine—Crohn's disease	0.000287	0.012	CcSEcCtD
Acetylsalicylic acid—PTGS2—gall bladder—Crohn's disease	0.000287	0.0103	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—Crohn's disease	0.000275	0.00989	CbGeAlD
Acetylsalicylic acid—Coma—Mesalazine—Crohn's disease	0.000269	0.0112	CcSEcCtD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—Crohn's disease	0.000261	0.305	CrCbGaD
Acetylsalicylic acid—PTGS2—mouth—Crohn's disease	0.000255	0.00918	CbGeAlD
Acetylsalicylic acid—Deafness—Mesalazine—Crohn's disease	0.000239	0.00995	CcSEcCtD
Acetylsalicylic acid—Peptic ulcer—Prednisone—Crohn's disease	0.000233	0.00971	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Mesalazine—Crohn's disease	0.000224	0.00936	CcSEcCtD
Acetylsalicylic acid—Thirst—Mesalazine—Crohn's disease	0.000224	0.00936	CcSEcCtD
Acetylsalicylic acid—EDNRA—lymph node—Crohn's disease	0.000224	0.00804	CbGeAlD
Acetylsalicylic acid—Anaemia—Mercaptopurine—Crohn's disease	0.000219	0.00913	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000214	0.00891	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Mercaptopurine—Crohn's disease	0.000212	0.00884	CcSEcCtD
Acetylsalicylic acid—IKBKB—lymph node—Crohn's disease	0.000203	0.0073	CbGeAlD
Acetylsalicylic acid—Arthralgia—Mercaptopurine—Crohn's disease	0.000202	0.00841	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000189	0.0079	CcSEcCtD
Acetylsalicylic acid—Influenza—Mesalazine—Crohn's disease	0.000185	0.0077	CcSEcCtD
Acetylsalicylic acid—Asthma—Mesalazine—Crohn's disease	0.000185	0.0077	CcSEcCtD
Acetylsalicylic acid—Contusion—Prednisone—Crohn's disease	0.000178	0.00744	CcSEcCtD
Acetylsalicylic acid—CYP2C19—digestive system—Crohn's disease	0.000167	0.00601	CbGeAlD
Acetylsalicylic acid—Ulcer—Prednisone—Crohn's disease	0.000165	0.00686	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Azathioprine—Crohn's disease	0.000163	0.0068	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Azathioprine—Crohn's disease	0.000162	0.00676	CcSEcCtD
Acetylsalicylic acid—Sweating—Mesalazine—Crohn's disease	0.000158	0.00658	CcSEcCtD
Acetylsalicylic acid—PTGS1—epithelium—Crohn's disease	0.000155	0.00559	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—Crohn's disease	0.000152	0.178	CrCbGaD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—Crohn's disease	0.00015	0.175	CrCbGaD
Acetylsalicylic acid—PTGS1—smooth muscle tissue—Crohn's disease	0.00015	0.00539	CbGeAlD
Acetylsalicylic acid—PTGS2—epithelium—Crohn's disease	0.000149	0.00534	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Mesalazine—Crohn's disease	0.000149	0.00619	CcSEcCtD
Acetylsalicylic acid—PTGS1—skin of body—Crohn's disease	0.000148	0.00532	CbGeAlD
Acetylsalicylic acid—Haemorrhage—Mesalazine—Crohn's disease	0.000148	0.00616	CcSEcCtD
Acetylsalicylic acid—PTGS2—smooth muscle tissue—Crohn's disease	0.000143	0.00515	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000143	0.00594	CcSEcCtD
Acetylsalicylic acid—PTGS2—skin of body—Crohn's disease	0.000141	0.00508	CbGeAlD
Acetylsalicylic acid—Tinnitus—Mesalazine—Crohn's disease	0.000138	0.00574	CcSEcCtD
Acetylsalicylic acid—PTGS1—mammalian vulva—Crohn's disease	0.000135	0.00485	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Mercaptopurine—Crohn's disease	0.000132	0.00552	CcSEcCtD
Acetylsalicylic acid—Anaemia—Azathioprine—Crohn's disease	0.000131	0.00544	CcSEcCtD
Acetylsalicylic acid—Diabetes mellitus—Prednisone—Crohn's disease	0.00013	0.00542	CcSEcCtD
Acetylsalicylic acid—CYP2C9—digestive system—Crohn's disease	0.00013	0.00466	CbGeAlD
Acetylsalicylic acid—Leukopenia—Azathioprine—Crohn's disease	0.000126	0.00527	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Prednisone—Crohn's disease	0.000126	0.00527	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mercaptopurine—Crohn's disease	0.000123	0.00513	CcSEcCtD
Acetylsalicylic acid—Rash—Mercaptopurine—Crohn's disease	0.000122	0.00508	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mercaptopurine—Crohn's disease	0.000122	0.00508	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Azathioprine—Crohn's disease	0.00012	0.00501	CcSEcCtD
Acetylsalicylic acid—Anaemia—Mesalazine—Crohn's disease	0.000119	0.00496	CcSEcCtD
Acetylsalicylic acid—ALB—lymph node—Crohn's disease	0.000119	0.00426	CbGeAlD
Acetylsalicylic acid—PTGS1—digestive system—Crohn's disease	0.000118	0.00425	CbGeAlD
Acetylsalicylic acid—Angioedema—Mesalazine—Crohn's disease	0.000118	0.0049	CcSEcCtD
Acetylsalicylic acid—Purpura—Prednisone—Crohn's disease	0.000117	0.00489	CcSEcCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—Crohn's disease	0.000117	0.136	CrCbGaD
Acetylsalicylic acid—Vertigo—Mesalazine—Crohn's disease	0.000116	0.00482	CcSEcCtD
Acetylsalicylic acid—Syncope—Mesalazine—Crohn's disease	0.000115	0.00481	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Mesalazine—Crohn's disease	0.000115	0.0048	CcSEcCtD
Acetylsalicylic acid—Nausea—Mercaptopurine—Crohn's disease	0.000115	0.00479	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymphoid tissue—Crohn's disease	0.000114	0.00411	CbGeAlD
Acetylsalicylic acid—Loss of consciousness—Mesalazine—Crohn's disease	0.000113	0.00471	CcSEcCtD
Acetylsalicylic acid—PTGS2—digestive system—Crohn's disease	0.000113	0.00406	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000113	0.00471	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Azathioprine—Crohn's disease	0.000113	0.0047	CcSEcCtD
Acetylsalicylic acid—Hypertension—Mesalazine—Crohn's disease	0.000111	0.00463	CcSEcCtD
Acetylsalicylic acid—Chest pain—Mesalazine—Crohn's disease	0.00011	0.00457	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mesalazine—Crohn's disease	0.00011	0.00457	CcSEcCtD
Acetylsalicylic acid—Confusional state—Mesalazine—Crohn's disease	0.000106	0.00441	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Mesalazine—Crohn's disease	0.000105	0.00438	CcSEcCtD
Acetylsalicylic acid—Shock—Mesalazine—Crohn's disease	0.000103	0.00431	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Prednisone—Crohn's disease	0.000103	0.00429	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mesalazine—Crohn's disease	0.000103	0.00429	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Mesalazine—Crohn's disease	0.000102	0.00427	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mesalazine—Crohn's disease	0.000101	0.00423	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Azathioprine—Crohn's disease	9.5e-05	0.00396	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mesalazine—Crohn's disease	9.36e-05	0.0039	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—PTGS2—Crohn's disease	9.35e-05	0.109	CrCbGaD
Acetylsalicylic acid—Somnolence—Mesalazine—Crohn's disease	9.33e-05	0.00389	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mesalazine—Crohn's disease	9.24e-05	0.00385	CcSEcCtD
Acetylsalicylic acid—ABCB1—epithelium—Crohn's disease	9.19e-05	0.0033	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Mesalazine—Crohn's disease	8.65e-05	0.00361	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Azathioprine—Crohn's disease	8.49e-05	0.00354	CcSEcCtD
Acetylsalicylic acid—Urticaria—Mesalazine—Crohn's disease	8.34e-05	0.00348	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—ALB—Crohn's disease	8.33e-05	0.0973	CrCbGaD
Acetylsalicylic acid—ABCB1—mammalian vulva—Crohn's disease	7.97e-05	0.00287	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Azathioprine—Crohn's disease	7.89e-05	0.00329	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisone—Crohn's disease	7.86e-05	0.00328	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—Crohn's disease	7.82e-05	0.00326	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Mesalazine—Crohn's disease	7.73e-05	0.00322	CcSEcCtD
Acetylsalicylic acid—Dizziness—Azathioprine—Crohn's disease	7.62e-05	0.00318	CcSEcCtD
Acetylsalicylic acid—Pruritus—Mesalazine—Crohn's disease	7.43e-05	0.0031	CcSEcCtD
Acetylsalicylic acid—Vomiting—Azathioprine—Crohn's disease	7.33e-05	0.00306	CcSEcCtD
Acetylsalicylic acid—Rash—Azathioprine—Crohn's disease	7.27e-05	0.00303	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Azathioprine—Crohn's disease	7.26e-05	0.00303	CcSEcCtD
Acetylsalicylic acid—Flushing—Prednisone—Crohn's disease	7.26e-05	0.00303	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mesalazine—Crohn's disease	7.18e-05	0.00299	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymphoid tissue—Crohn's disease	7.08e-05	0.00255	CbGeAlD
Acetylsalicylic acid—ABCB1—digestive system—Crohn's disease	6.99e-05	0.00251	CbGeAlD
Acetylsalicylic acid—Dizziness—Mesalazine—Crohn's disease	6.94e-05	0.00289	CcSEcCtD
Acetylsalicylic acid—Nausea—Azathioprine—Crohn's disease	6.85e-05	0.00285	CcSEcCtD
Acetylsalicylic acid—PTGS1—lymph node—Crohn's disease	6.75e-05	0.00243	CbGeAlD
Acetylsalicylic acid—Vomiting—Mesalazine—Crohn's disease	6.68e-05	0.00278	CcSEcCtD
Acetylsalicylic acid—Rash—Mesalazine—Crohn's disease	6.62e-05	0.00276	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mesalazine—Crohn's disease	6.61e-05	0.00276	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—Crohn's disease	6.46e-05	0.00232	CbGeAlD
Acetylsalicylic acid—Anaemia—Prednisone—Crohn's disease	6.29e-05	0.00262	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—Crohn's disease	6.25e-05	0.00261	CcSEcCtD
Acetylsalicylic acid—Nausea—Mesalazine—Crohn's disease	6.24e-05	0.0026	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisone—Crohn's disease	6.22e-05	0.00259	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—Crohn's disease	6.11e-05	0.00255	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—Crohn's disease	6.1e-05	0.00254	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisone—Crohn's disease	5.98e-05	0.00249	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—Crohn's disease	5.9e-05	0.00246	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—Crohn's disease	5.88e-05	0.00245	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—Crohn's disease	5.79e-05	0.00242	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—Crohn's disease	5.55e-05	0.00232	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisone—Crohn's disease	5.46e-05	0.00228	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—Crohn's disease	5.42e-05	0.00226	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—Crohn's disease	5.37e-05	0.00224	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—Crohn's disease	4.89e-05	0.00204	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisone—Crohn's disease	4.58e-05	0.00191	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisone—Crohn's disease	4.41e-05	0.00184	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisone—Crohn's disease	4.09e-05	0.00171	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—Crohn's disease	3.99e-05	0.00144	CbGeAlD
Acetylsalicylic acid—Pruritus—Prednisone—Crohn's disease	3.93e-05	0.00164	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—Crohn's disease	3.8e-05	0.00158	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisone—Crohn's disease	3.67e-05	0.00153	CcSEcCtD
Acetylsalicylic acid—Vomiting—Prednisone—Crohn's disease	3.53e-05	0.00147	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—Crohn's disease	3.5e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—Crohn's disease	3.5e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisone—Crohn's disease	3.3e-05	0.00138	CcSEcCtD
Acetylsalicylic acid—IKBKB—Signaling by NGF—JAK2—Crohn's disease	6.81e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IFNG—Crohn's disease	6.8e-06	0.000111	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL2RA—Crohn's disease	6.77e-06	0.000111	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—RASGRP1—Crohn's disease	6.76e-06	0.000111	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RSPO3—Crohn's disease	6.73e-06	0.00011	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—RASGRP1—Crohn's disease	6.68e-06	0.00011	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.67e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TNF—Crohn's disease	6.62e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—UBE2D1—Crohn's disease	6.61e-06	0.000108	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—UBE2D1—Crohn's disease	6.61e-06	0.000108	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—SMAD3—Crohn's disease	6.6e-06	0.000108	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	6.58e-06	0.000108	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ICAM1—Crohn's disease	6.57e-06	0.000108	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.52e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—STAT3—Crohn's disease	6.5e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—STAT3—Crohn's disease	6.49e-06	0.000106	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PLA2G4F—Crohn's disease	6.45e-06	0.000106	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CCR6—Crohn's disease	6.41e-06	0.000105	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—RIPK2—Crohn's disease	6.41e-06	0.000105	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—RIPK2—Crohn's disease	6.41e-06	0.000105	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CRP—Crohn's disease	6.39e-06	0.000105	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SEL1L—Crohn's disease	6.38e-06	0.000105	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—IL6—Crohn's disease	6.35e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.35e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR9—Crohn's disease	6.25e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL3—Crohn's disease	6.25e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL3—Crohn's disease	6.25e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	6.22e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TYK2—Crohn's disease	6.15e-06	0.000101	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-Like Receptors Cascades—IL6—Crohn's disease	6.15e-06	0.000101	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SOCS1—Crohn's disease	6.12e-06	0.0001	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—TLR4—Crohn's disease	6.12e-06	0.0001	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL2RA—Crohn's disease	6.12e-06	0.0001	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL1B—Crohn's disease	6.07e-06	9.94e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SOCS1—Crohn's disease	6.05e-06	9.92e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—RASGRP1—Crohn's disease	6.04e-06	9.9e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—RASGRP1—Crohn's disease	6.04e-06	9.9e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—IL6—Crohn's disease	5.96e-06	9.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.95e-06	9.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.9e-06	9.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	5.87e-06	9.62e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—JAK2—Crohn's disease	5.87e-06	9.62e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ICAM1—Crohn's disease	5.87e-06	9.62e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PTPN2—Crohn's disease	5.86e-06	9.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	5.86e-06	9.6e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.85e-06	9.58e-05	CbGpPWpGaD
Acetylsalicylic acid—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	5.82e-06	9.55e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GPR65—Crohn's disease	5.81e-06	9.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—RBX1—Crohn's disease	5.8e-06	9.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	5.74e-06	9.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—LTF—Crohn's disease	5.72e-06	9.38e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TNF—Crohn's disease	5.62e-06	9.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TNF—Crohn's disease	5.61e-06	9.19e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CD4—Crohn's disease	5.56e-06	9.12e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PTGS2—Crohn's disease	5.52e-06	9.05e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—JAK2—Crohn's disease	5.48e-06	8.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTMR3—Crohn's disease	5.48e-06	8.99e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SOCS1—Crohn's disease	5.47e-06	8.97e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SOCS1—Crohn's disease	5.47e-06	8.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CRP—Crohn's disease	5.45e-06	8.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—FADS1—Crohn's disease	5.38e-06	8.82e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—TYK2—Crohn's disease	5.34e-06	8.75e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SMAD3—Crohn's disease	5.29e-06	8.67e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—ALB—Crohn's disease	5.29e-06	8.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	5.25e-06	8.6e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—TLR4—Crohn's disease	5.23e-06	8.57e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SMAD3—Crohn's disease	5.23e-06	8.57e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—TYK2—Crohn's disease	5.22e-06	8.56e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—TYK2—Crohn's disease	5.22e-06	8.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLA2G4F—Crohn's disease	5.22e-06	8.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.17e-06	8.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	5.13e-06	8.4e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—JAK2—Crohn's disease	5.09e-06	8.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—STAT3—Crohn's disease	5.08e-06	8.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—UBE2D1—Crohn's disease	5.08e-06	8.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GPX4—Crohn's disease	5.04e-06	8.26e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—CXCL8—Crohn's disease	5e-06	8.2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—STAT3—Crohn's disease	5e-06	8.19e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IFNG—Crohn's disease	5e-06	8.19e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—JAK2—Crohn's disease	4.98e-06	8.16e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—JAK2—Crohn's disease	4.98e-06	8.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—ITGA4—Crohn's disease	4.97e-06	8.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—RIPK2—Crohn's disease	4.93e-06	8.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ITGA4—Crohn's disease	4.93e-06	8.08e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL2RA—Crohn's disease	4.9e-06	8.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GCKR—Crohn's disease	4.87e-06	7.98e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL3—Crohn's disease	4.84e-06	7.94e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL2RA—Crohn's disease	4.84e-06	7.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD4—Crohn's disease	4.82e-06	7.91e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ICAM1—Crohn's disease	4.81e-06	7.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL3—Crohn's disease	4.81e-06	7.88e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—TYK2—Crohn's disease	4.77e-06	7.82e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	4.74e-06	7.77e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SMAD3—Crohn's disease	4.73e-06	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SMAD3—Crohn's disease	4.73e-06	7.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—RASGRP1—Crohn's disease	4.68e-06	7.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	4.68e-06	7.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—RASGRP1—Crohn's disease	4.65e-06	7.62e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD79A—Crohn's disease	4.63e-06	7.59e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	4.63e-06	7.59e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTGS2—Crohn's disease	4.63e-06	7.58e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—GCKR—Crohn's disease	4.61e-06	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLA2G4F—Crohn's disease	4.57e-06	7.49e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—JAK2—Crohn's disease	4.55e-06	7.46e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TAB1—Crohn's disease	4.55e-06	7.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CXCL8—Crohn's disease	4.54e-06	7.45e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CXCL8—Crohn's disease	4.54e-06	7.45e-05	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL6—Crohn's disease	4.54e-06	7.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—IL6—Crohn's disease	4.53e-06	7.43e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—Crohn's disease	4.48e-06	7.34e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NOD2—Crohn's disease	4.47e-06	7.32e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IFNG—Crohn's disease	4.47e-06	7.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTMR3—Crohn's disease	4.46e-06	7.31e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1B—Crohn's disease	4.46e-06	7.3e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTMR3—Crohn's disease	4.44e-06	7.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	4.42e-06	7.25e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2RA—Crohn's disease	4.38e-06	7.17e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2RA—Crohn's disease	4.38e-06	7.17e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD4—Crohn's disease	4.31e-06	7.07e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TYK2—Crohn's disease	4.31e-06	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—STAT3—Crohn's disease	4.31e-06	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—FADS1—Crohn's disease	4.27e-06	7e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	4.27e-06	7e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SOCS1—Crohn's disease	4.21e-06	6.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR6—Crohn's disease	4.14e-06	6.79e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—JAK2—Crohn's disease	4.11e-06	6.74e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.1e-06	6.72e-05	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	4.09e-06	6.7e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SLC11A1—Crohn's disease	4.08e-06	6.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—TYK2—Crohn's disease	4.07e-06	6.68e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—Crohn's disease	4e-06	6.56e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GPX4—Crohn's disease	4e-06	6.56e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1B—Crohn's disease	3.98e-06	6.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.98e-06	6.53e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.9e-06	6.4e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTMR3—Crohn's disease	3.89e-06	6.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—JAK2—Crohn's disease	3.88e-06	6.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GCKR—Crohn's disease	3.86e-06	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL18—Crohn's disease	3.79e-06	6.21e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CXCL8—Crohn's disease	3.75e-06	6.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RBX1—Crohn's disease	3.75e-06	6.14e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—STAT3—Crohn's disease	3.74e-06	6.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD4—Crohn's disease	3.68e-06	6.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTGER4—Crohn's disease	3.65e-06	5.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTMR3—Crohn's disease	3.63e-06	5.95e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—Crohn's disease	3.55e-06	5.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD4—Crohn's disease	3.54e-06	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HSPA1B—Crohn's disease	3.5e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RBX1—Crohn's disease	3.5e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—Crohn's disease	3.49e-06	5.72e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.48e-06	5.7e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—FADS1—Crohn's disease	3.48e-06	5.7e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—FADS1—Crohn's disease	3.46e-06	5.66e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TYK2—Crohn's disease	3.45e-06	5.65e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TYK2—Crohn's disease	3.41e-06	5.59e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2RA—Crohn's disease	3.39e-06	5.56e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2RA—Crohn's disease	3.37e-06	5.52e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—STAT3—Crohn's disease	3.34e-06	5.47e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—JAK2—Crohn's disease	3.29e-06	5.39e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—UBE2D1—Crohn's disease	3.29e-06	5.39e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GPX4—Crohn's disease	3.25e-06	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—JAK2—Crohn's disease	3.25e-06	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GPX4—Crohn's disease	3.24e-06	5.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RIPK2—Crohn's disease	3.19e-06	5.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CRP—Crohn's disease	3.18e-06	5.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GCKR—Crohn's disease	3.14e-06	5.15e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GCKR—Crohn's disease	3.13e-06	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL3—Crohn's disease	3.11e-06	5.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—FADS1—Crohn's disease	3.1e-06	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TYK2—Crohn's disease	3.08e-06	5.05e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TYK2—Crohn's disease	3.08e-06	5.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—UBE2D1—Crohn's disease	3.07e-06	5.02e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TLR4—Crohn's disease	3.04e-06	4.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.04e-06	4.99e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—FADS1—Crohn's disease	3.03e-06	4.96e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—STAT3—Crohn's disease	3.02e-06	4.94e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—Crohn's disease	3.01e-06	4.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RASGRP1—Crohn's disease	3.01e-06	4.93e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CXCL8—Crohn's disease	3e-06	4.92e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CXCL8—Crohn's disease	2.97e-06	4.87e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—JAK2—Crohn's disease	2.94e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—JAK2—Crohn's disease	2.94e-06	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ICAM1—Crohn's disease	2.92e-06	4.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GPX4—Crohn's disease	2.9e-06	4.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GPX4—Crohn's disease	2.84e-06	4.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—FADS1—Crohn's disease	2.83e-06	4.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GCKR—Crohn's disease	2.81e-06	4.6e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.77e-06	4.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.76e-06	4.52e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GCKR—Crohn's disease	2.74e-06	4.49e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SOCS1—Crohn's disease	2.72e-06	4.46e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CXCL8—Crohn's disease	2.68e-06	4.4e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CXCL8—Crohn's disease	2.68e-06	4.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GPX4—Crohn's disease	2.65e-06	4.34e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—Crohn's disease	2.61e-06	4.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GCKR—Crohn's disease	2.56e-06	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—Crohn's disease	2.55e-06	4.18e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—Crohn's disease	2.55e-06	4.18e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—STAT3—Crohn's disease	2.42e-06	3.96e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—STAT3—Crohn's disease	2.39e-06	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TYK2—Crohn's disease	2.37e-06	3.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SMAD3—Crohn's disease	2.35e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—Crohn's disease	2.33e-06	3.82e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—JAK2—Crohn's disease	2.28e-06	3.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—JAK2—Crohn's disease	2.26e-06	3.71e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.25e-06	3.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNG—Crohn's disease	2.22e-06	3.64e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SMAD3—Crohn's disease	2.19e-06	3.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2RA—Crohn's disease	2.18e-06	3.57e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STAT3—Crohn's disease	2.16e-06	3.54e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STAT3—Crohn's disease	2.16e-06	3.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD4—Crohn's disease	2.15e-06	3.52e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—Crohn's disease	2.11e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2e-06	3.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—Crohn's disease	1.99e-06	3.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—Crohn's disease	1.98e-06	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.97e-06	3.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.95e-06	3.2e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.86e-06	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.83e-06	3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.75e-06	2.88e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—Crohn's disease	1.69e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—Crohn's disease	1.67e-06	2.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—Crohn's disease	1.66e-06	2.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.6e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—Crohn's disease	1.55e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TYK2—Crohn's disease	1.53e-06	2.51e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—Crohn's disease	1.51e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—Crohn's disease	1.51e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JAK2—Crohn's disease	1.46e-06	2.4e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TYK2—Crohn's disease	1.43e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—JAK2—Crohn's disease	1.36e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—Crohn's disease	1.35e-06	2.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—Crohn's disease	1.34e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—Crohn's disease	1.29e-06	2.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—Crohn's disease	1.23e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—Crohn's disease	1.16e-06	1.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—Crohn's disease	1.07e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—Crohn's disease	1e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—Crohn's disease	1e-06	1.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—Crohn's disease	8.93e-07	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—Crohn's disease	8.75e-07	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—Crohn's disease	8.71e-07	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—Crohn's disease	8.7e-07	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—Crohn's disease	8.14e-07	1.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—Crohn's disease	7.81e-07	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—Crohn's disease	7.62e-07	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—Crohn's disease	7.5e-07	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—Crohn's disease	7.12e-07	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—Crohn's disease	7e-07	1.15e-05	CbGpPWpGaD
